Xilio Therapeutics's total assets for Q3 2023 were $77.84M, a decrease of -15.73% from the previous quarter. XLO total liabilities were $25.34M for the fiscal quarter, a 1.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.